Targeting chaperones in transformed systems – a focus on Hsp90 and cancer

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.10, Iss.1, 2006-02, pp. : 37-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of HSP90 and other chaperones for the treatment of cancer

By Dymock Brian W Drysdale Martin J McDonald Edward Workman Paul

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 6, 2004-06 ,pp. : 837-847

Informa Healthcare

Access to resources Recommend Favorite

Hsp90: A Novel Target for Cancer Therapy

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-06 ,pp. : 1205-1214

Bentham Science Publishers

Access to resources Recommend Favorite

Effectiveness of Hsp90 Inhibitors as Anti-Cancer Drugs

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 10, 2006-10 ,pp. : 1137-1143

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Target Hsp90 and Cancer Hallmarks

Current Pharmaceutical Design, Vol. 19, Iss. 3, 2013-01 ,pp. : 347-365

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Hsp90-Cdc37: A Promising Therapeutic Strategy by Inhibiting Hsp90 Chaperone Function

Current Drug Targets, Vol. 18, Iss. 13, 2017-09 ,pp. : 1572-1585

Bentham Science Publishers

Access to resources Recommend Favorite